Edmunds Kim, Wang Yufan, Sara Sally, Riley Bernie, Heneka Nicole, Tuffaha Haitham
Centre for the Business and Economics of Health (CBEH), University of Queensland, St Lucia, Australia.
Prostate Cancer Foundation of Australia (PCFA), Sydney, Australia.
Psychooncology. 2025 May;34(5):e70181. doi: 10.1002/pon.70181.
In Australia, Prostate cancer (PCa) has a high survival rate (96%) meaning men with PCa may live with the impact of the disease for many years, even decades. The Prostate Cancer Foundation of Australia (PCFA) manages two Prostate Cancer Specialist Nursing (PCSN) programs: (1) A health service-based program and (2) A telenursing service. There is a paucity of economic evidence regarding the benefits of these programs so Social Return on Investment (SROI) methodology was used to determine social value and return on investment.
A SROI economic evaluation model was developed in consultation with the PCSN team augmented with published evidence to identify the costs and outcomes, and estimate the benefits associated with the delivery of the PCSN program over 2 years. Attribution, dead weight loss and discounting were calculated and sensitivity analyses were conducted to test the rigour of the model.
The value generated by the PCSN programs over the 2-year period resulted in a SROI ratio of 1:1.62 for the health service-based PCSN program, indicating that for every dollar invested, a return of AUD $1.62 was obtained. The SROI ratios for the Telenursing program and the combined programs were 1:2.34 and 1:1.65, respectively.
Our study provides evidence that further expansion of the PCSN program is likely to have a positive return on investment and benefit the 250,000 men currently living with PCa in Australia. Findings such as these are important in informing cancer care policy and funding decisions.
在澳大利亚，前列腺癌（PCa）的生存率很高（96%），这意味着患有前列腺癌的男性可能在疾病的影响下生活多年，甚至数十年。澳大利亚前列腺癌基金会（PCFA）管理着两个前列腺癌专科护理（PCSN）项目：（1）一个基于健康服务的项目和（2）一个远程护理服务。关于这些项目益处的经济证据很少，因此采用社会投资回报率（SROI）方法来确定社会价值和投资回报率。
与PCSN团队协商开发了一个SROI经济评估模型，并辅以已发表的证据来确定成本和结果，估计在两年内提供PCSN项目相关的收益。计算了归属、无谓损失和贴现，并进行了敏感性分析以检验模型的严谨性。
PCSN项目在两年期间产生的价值使得基于健康服务的PCSN项目的SROI比率为1:1.62，这表明每投资1澳元可获得1.62澳元的回报。远程护理项目和综合项目的SROI比率分别为1:2.34和1:1.65。
我们的研究提供了证据，表明进一步扩大PCSN项目可能会有积极的投资回报，并使澳大利亚目前患有前列腺癌的25万名男性受益。这样的研究结果对于为癌症护理政策和资金决策提供信息很重要。
